BioPharma Credit (BPCR)

$ 0.89
   
  • Change Today:
    $0.01
  • 52 Week High: $0.9
  • 52 Week Low: $0.8
  • Currency: US Dollars
  • Shares Issued: 1,135.08m
  • Volume: 656,256
  • Market Cap: $1,007.95m
  • RiskGrade: 32
  • Beta: 0.01

BPCR Overview

BioPharma Credit plc provides investors with an opportunity to gain exposure to the fast growing life sciences industry, through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. BioPharma Credit’s primary objective is to generate predictable income for shareholders over the long term.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 7.9% 0.0%
Div Cover 1.4 n/a
Op Mrgn 82.3% n/a
ROCE 10.3%  
Latest F'cast
P/E 8.9 n/a
PEG n/a n/a
Pr/Revenue 6.8 n/a
Pr/Book 0.9  
Latest F'cast
Revenue -4.3% n/a
PBT -7.7% n/a
EPS -1.1% n/a
DPS n/a n/a

BPCR Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 100.55 79.67 5.80¢ 17.2 n/a -30% 7.00¢ 7.0%
31-Dec-21 127.63 108.73 7.91¢ 12.2 0.3 +36% 7.00¢ 7.2%
31-Dec-22 212.22 176.39 12.93¢ 7.3 0.1 +64% 7.00¢ 7.4%
31-Dec-23 155.36 132.40 10.11¢ 8.3 n/a -22% 7.00¢ 8.3%
31-Dec-24 148.63 122.27 10.00¢ 8.8 n/a -1% 7.00¢ 7.9%

BPCR Company Announcements

Transaction in Own Shares 27-Mar-2025 18:15 RNS
Transaction in Own Shares 26-Mar-2025 18:15 RNS
Transaction in Own Shares 25-Mar-2025 18:15 RNS

BPCR ShareCast News

BioPharma Credit puts $165m into pharma firm Col... 07-Feb-2020 ShareCast
BioPharma Credit pours cash into US firms Epizym... 13-Nov-2019 ShareCast
BioPharma Credit increases placing following 'st... 24-Oct-2018 ShareCast

Latest BPCR Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

BPCR Market Data

Currency US Dollars
Share Price $ 0.89
Change Today $ 0.01
% Change 1.14 %
52 Week High $0.9
52 Week Low $0.8
Volume 656,256
Shares Issued 1,135.08m
Market Cap $1,007.95m
Beta 0.01
RiskGrade 32

BPCR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

BPCR Dividends

  Latest Previous
  1st Interim Special
Ex-Div 03-Apr-25 30-Jan-25
Paid 07-May-25 28-Feb-25
Amount 1.75¢ 1.14¢

Trades for 28-Mar-2025

Time Volume / Share Price
16:35 10,407 @ $0.89
16:35 8,338 @ $0.89
16:35 48 @ $0.89
16:35 361 @ $0.89
16:35 409 @ $0.89

BPCR Key Personnel

Chair Harry Abraham Hyman

Top of Page